GATM and central nervous system cancer: As AGAT removes methyl adducts from DNA via a suicide mechanism, it has also been suggested that protracted exposure to an alkylating agent may not only saturate AGAT copies available within cancer cells, but may also inactivate the new molecules while they are being synthesised, thus leading to AGAT ‘depletion’ and overcoming the inherent resistance of glioma cells.